Disease burden and conditioning regimens in ASCT1221, a randomized phase II trial in children with juvenile myelomonocytic leukemia: A Children's Oncology Group study. [electronic resource]
Producer: 20190506Description: e27034 p. digitalISSN:- 1545-5017
- Busulfan -- administration & dosage
- Child
- Child, Preschool
- Female
- Follow-Up Studies
- Graft Rejection -- drug therapy
- Graft vs Host Disease -- drug therapy
- Hematopoietic Stem Cell Transplantation -- adverse effects
- Humans
- Infant
- Infant, Newborn
- Leukemia, Myelomonocytic, Juvenile -- complications
- Male
- Myeloablative Agonists -- administration & dosage
- Prognosis
- Transplantation Conditioning
- Vidarabine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.